LHM-123

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLHM-123
Drug Alias NameAlzheimers disease therapy (APPI)MAALZ program (Mazal Plant Pharmaceuticals)LHM-123
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A